ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Three effective treatments for COVID-19 not (yet) in guidelines"
Episode Synopsis
Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.
More episodes of the podcast Let's Talk ID
Blending Art, Medicine and Charity
27/09/2025
Let's Talk HIV: Street Medicine
21/08/2025
The Cost of Cutting Public Health (Pt. 2)
14/06/2025
The Cost of Cutting Public Health (Pt. 1)
02/06/2025
In God we trust